IGC Pharma Activates New Clinical Trial Site At Tandem Clinical Research A Prolerity Network Site In Metairie, Louisiana, For Ongoing Phase 2 CALMA Clinical Trial Evaluating IGC-AD1 For Agitation In Alzheimer's Dementia

Benzinga Newsdesk www.benzinga.com Neutral 55.2%

Neg 0% Neu 55.2% Pos 0%

Comments

No comments yet. Be the first!